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REQUIREMENT FOR THE COEXPRESSION OF T3 AND 
THE T CELL  ANT IGEN RECEPTOR ON A MAL IGNANT 
HUMAN T CELL  L INE 
BY ARTHUR WEISS AND JOHN D. STOBO 
From the Department ofMedicine and the Howard Hughes Medical Institute, University of 
California, San Francisco, California 94143 
During the past year, several laboratories have developed monoclonal antibod- 
ies reactive with idiotypic-like determinants expressed on human and murine T 
cell clones, lines, or hybridomas (1-5). These antibodies are felt to react with 
the antigen receptors of these cells. Such antibodies can mimic the effects of 
antigen by specifically activating the immunizing T cell, or, under appropriate 
circumstances, can specifically block the antigen reactivity of the immunizing T 
cell (2-7). Immunoprecipitates prepared from different cells with such antibodies 
contain distinct heterodimers of 80-90 kilodaltons (kD) under nonreducing 
conditions and two chains of 37-52 kD under reducing conditions (1-7). 
On human cells, another set of molecules, T3, has been associated with such 
putative T cell antigen receptors. T3 consists of at least three noncovalently 
linked distinct peptides, each of which has not been shown to exhibit any 
structural or antigenic polymorphism (8). Several observations have suggested 
an association between T3 and the putative antigen receptor: T3 co-modulates 
with antigen receptor determinants on T cell clones (2); the induction of an 
unresponsive state in T cell clones exposed to soluble antigen is accompanied by 
a diminished expression of T3 (9); T3 and receptor binding sites are stoichio- 
metric (10); immunoprecipitates of T3, under some conditions, contain the T 
cell receptor heterodimer in addition to the peptides representing T3 (11); and 
the appearance of T3 during T cell ontogeny has been linked to the expression 
of antigen receptor-like molecules on T cells (12). Despite these observations, 
however, the role of T3 in this association has not been defined. 
T3 may play a critical role in T cell activation. Monoclonal antibodies reactive 
with T3 can provide one of the two requisite signals required for T cell activation 
(13-15). Thus, such antibodies can induce T cell activation in a manner analo- 
gous to that noted with antigen or anti-receptor antibodies. This transmembrane 
activation signal is mediated by an increase in cytoplasmic free calcium (16). The 
studies reported here examined the association between T3 and antigen recep- 
tor-like molecules expressed on a functional human T cell line, Jurkat, using 
mutants of Jurkat. These studies demonstrate hat there appears to be an obligate 
requirement for the coexpression of T3 and the antigen receptor. Moreover, 
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the expression of these molecules appears to be required for the activation of 
Jurkat cells by the lectin phytohemagglutinin (PHA)) 
Materials and Methods 
Cells. An interleukin 2 (IL-2)-producing clone ofJurkat, E6-1, and mutants of this 
clone (described below) were passaged in RPMI 1640 supplemented with 10% fetal bovine 
serum as previously described (15). CTLL-20, a mouse IL-2-dependent T cell line, was 
passaged in IL-2-supplemented medium as previously described (15). 
Monoclonal Antibodies. A monoclonal antibody with specificity for an anugen receptor- 
like molecule expressed on Jurkat was derived from a fusion between SP-2/0 mouse 
myeloma cells and spleen cells from BALB/c mice that had been immunized intraperito- 
neally with 5 x l0 s Jurkat cells every month for 3 mo. The fusion was performed 
according to previously described methods 3 d after an intravenous immunization with 
the same number of Jurkat cells (17). One hybrid, C305, proved to be specifically reactive 
with Jurkat. Culture supernatant fluid or ascitic fluid from this hybridoma was used for 
the studies described in this report. Another antibody derived from this fusion, C373, 
proved to be reactive with the proteins associated with the E rosette receptor on human 
T cells, based on its T cell specificity, ability to inhibit E rosette formation, and immuno- 
precipitation of a 55 kD peptide on T cells. Both C305 and C373 are IgM kappa 
immunoglobulins. OKT3, anti-Leu-4, 64.1, anti-Leu-1, anti-Leu-5, W6]32, MOPC-195, 
and MOPC-104E (IgM) monocional antibodies were obtained from previously described 
sources (15). 
Preparation of Radioiodinated Cell Surface Proteins. Iodination of cell surface molecules 
was performed using glucose oxidase catalyzation of the lactoperoxidase t chnique (18). 
Cells were lysed at 4.0 x 107/ml in ice-cold lysis buffer containing 1.0% Nonidet-40 
(Particle Data, Inc., Elmhurst, IL), phenylmethylsulfonyl fluoride (1 raM) and benzamidine 
(1 mM) in 0.01 M Tris-HC1, pH 8.0, and iodoacetamide, 10 mM, in 0.15 M NaC1 (lysis 
buffer). After 30 rain of incubation at 4°C, nuclei and large debris were removed by 
centrifugation. Lysates were then precleared with formalin-fixed Staphylococcus aureus 
(Calbiochem-Behring Corp., La Jolla, CA), centrifuged at 100,000 g for 30 min, and 
supernatants were stored at -70°C. 
Characterization of Radioiodinated Cell Surface Proteins. Cell surface molecules were 
characterized using the immunoisolation technique described by Tamura et al. (19). One- 
dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of 
isolated cell surface proteins was performed on 10% acrylamide slab gels with a discontin- 
uous buffer system according to previously described methods (20). The molecular weight 
standards (Pharmacia Fine Chemicals, Piscataway, N J) run in parallel anes were visualized 
using Coomassie Blue staining. 
Diagonal, two-dimensional SDS-PAGE was performed on whole cell lysates or isolated 
proteins under nonreducing conditions in the first dimension using tubes containing a 0.2 
x 10-cm 10% gel with a 0.2 x 1-cm 3% stacking el. Gels were then equilibrated in SDS 
sample buffer containing 5% 2-mercaptoethanol f r 30 min at 22°C and the second 
dimension electrophoresis was performed using a 10% acrylamide slab gel. Autoradi- 
ographs of the dried gels were visualized using intensifying screens and Kodak XAR-5 
film. 
Derivation of Jurkat Mutants. Mutants of Jurkat cells were produced by exposing cells 
to ethyl methane sulfonate (EMS) (Sigma Chemical Co., St. Louis, MO), 200 #g/ml, for 
24 h or to 200 rad of gamma radiation (cesium source). After an additional 5d of culture, 
1-2 x 106 mutagenized cells were negatively selected with OKT3 (1:100 final dilution) 
or C305 ascitic fluid (1:100 final dilution) and rabbit serum (1:8 final dilution) as a source 
of complement for 60 min at 37°C. This negative selection was performed at least three 
l Abbreviations u ed in this paper: EMS, ethyl methane sulfonate; IL-2, interleukin 2; MCF, mean 
channel fluorescence; MHC, major histocompatibility complex; PBL, peripheral blood monocytes; 
PHA, phytohemagglutinin; PMA, phorbol myristate acetate; SDS, sodium dodecyl sulfate; SDS- 
PAGE, SDS-polyacrylamide el ctrophoresis. 
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times over a 2 wk period. Positive selection of T3- or C305-negative c lls was performed 
using indirect immunofluorescence and sorting negative cells by flow cytometry as 
previously described (16). Positive selection was always performed by staining the treated 
cells with the same antibody used in the negative selection treatment. Sorted negative 
cells were cloned by limiting dilution. 
Indirect lmmunofluorescence, Flow Cytometric Analysis, and Sorting. Cells were stained 
with hybridoma supernatants (undiluted) or commercial ntibodies followed by fluores- 
ceinated F(ab')2 goat anti-mouse Ig (Cappel Laboratories, Cochranville, PA) as previously 
described (15). Cell were analyzed and sorted sterilely on a FACS IV fluorescence- 
activated cell sorter (Becton, Dickinson & Co, Sunnyvale, CA) according to previously 
described methods (16). 
Quantitative Absorption Studies. Serial twofold dilutions of cells used for absorptions 
were incubated in 100 #I of OKT3 (1:800) or C305 ascitic fluid (1:I000) for 30 rain at 
22 °C. Supernatants were collected and 50 #i were added to 25 #1 of medium containing 
104 Jurkat cells labeled with ~lCr according to previously described methods (17). To this, 
25 #1 of a 1:8 dilution of rabbit serum that had been preabsorbed with Jurkat cells was 
added. Cells were incubated for 60 min at 37°C and the percent specific ~Cr release was 
determined as previously described (17). 
Stimulation of Jurkat and Mutants and Determination f lL-2 Activity. Jurkat or mutant 
cells were stimulated at 1 x l0 B cells/ml in microtiter wells as previously described (15). 
The final concentration f the stimulating agents was: PHA (Burroughs Wellcome Co., 
Research Triangle Park, NC), 1 #g/ml; phorbol myristate acetate (PMA) (Sigma Chemical 
Co.), 50 ng/ml; commercial monoclonal ntibodies, 1:100 dilution; C305 or C373 hybri- 
doma culture supernatant, 1:20-1:100 dilution; and A23187 (Calbiochem-Behring Corp.), 
1 #g/ml. After 24 h of culture, cell-free supernatants were assessed for IL-2 activity using 
the IL-2-dependent line, CTLL-20, according to previously described methods (15). The 
lower limit of detection in this assay is 2.0 U/ml. 
Results 
Characterization of the Molecules Recognized by Monoclonal Antibody C305. To 
study the association between T3 and the antigen receptor, a monoclonal 
antibody (C305) reactive with a putative antigen receptor expressed on the T3- 
positive human T cell line, Jurkat, was produced. C305 reacted with Jurkat but 
failed to react with B cell lines, peripheral blood lymphocytes (PBL), or other T 
cell lines as assessed by indirect immunofluorescence or antibody and comple- 
ment-mediated cytotoxicity. Moreover, C305 failed to react with two other 
available T3-positive human T cell lines, HUT 78 and PEER. Fig. 1 depicts the 
flow cytometer fluorescent histograms obtained with Jurkat, PBL, and HUT 78 
stained with OKT3 (reactive with T3), C305, and anti-Leu-1 (reactive with T1). 
As is evident, C305 appears to react with an antigenic determinant uniquely 
expressed on Jurkat. This is contrasted by the histograms obtained with OKT3 
or anti-Leu-1 which reacted with 95% of Jurkat or HUT 78 cells as well as with 
the T cells within the PBL population. 
The nature of the molecules bearing determinants with which C305 reacted 
were defined by isolation of radioiodinated Jurkat cell surface proteins. By one- 
dimensional SDS-PAGE, the protein with which C305 reacted migrated as a 
diffuse band of 80-90 kD under nonreducing conditions (Fig. 2F). Under 
reducing conditions, this protein could be resolved into two major peptides of 
42 and 54 kD (Fig. 2,E). In some studies performed under reducing conditions 
(see below), a third band of intermediate molecular mass has been visualized, 
perhaps representing a degradation product or an incompletely glycosylated 
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FIGURE 1. C305 reacts with idiotypic-like determinants expressed on Jurkat. Shown are 
fluorescence histograms obtained on a flow cytometer of Jurkat cells (A-C), PBL (D-F), and 
HUT 78 cells (G-I) stained by indirect immunofluorescence with antibodies of the indicated 
specificities (heavy lines). In each case, the histogram obtained with a nonreactive control 
antibody (light line) is shown for comparison. 
form of the 54 kD band. Similar observations have been made in the murine 
system (5). Thus, this heterodimer isolated from Jurkat is very similar in molec- 
ular mass to the putative T cell receptors isolated by others from human T cell 
clones and lines (1-5). C305 reacts with a molecule distinctly different from T3 
which is represented by the broad band of 22-24 kD and the band of 28 kD 
isolated from Jurkat using an anti-T3 monoclonal antibody (Fig. 2B). These 
results, together with the cell specificity data, suggest hat C305 reacts with 
idiotypic-like determinants expressed on a heterodimer with structural charac- 
teristics of the putative T cell antigen receptor. 
C305 Can Activate Jurkat Cells. Previous studies demonstrated that Jurkat 
cells could be activated to produce IL-2 by PHA (15, 16, 21). This response was 
greatly augmented by the phorbol ester, PMA. Anti-T3 monoclonai antibodies 
could activate Jurkat to produce IL-2, but only if PMA was also added (Table I; 
0 vs. 109 U/mi of IL-2) (15). In agreement with previous results from this 
laboratory (15), monoclonal antibodies reactive with T1, T11, or HLA deter- 
minants failed to activate Jurkat even in the presence of PMA (Table I). A 
monoclonai ntibody reactive with an antigen receptor on a responsive cell might 
be expected to function in a manner analogous to antigen by its ability to activate 
the cell. Jurkat cells could, indeed, be activated by C305 if PMA was added 
(Table I). The magnitude of the response to C305 plus PMA was comparable to 
that obtained with OKT3 plus PMA (119 vs. 109 U/ml, respectively). Thus, the 
clonotypic antibody C305, which has specificity for an 80-90 kD heterodimer, 
could activate Jurkat, supporting the notion that C305 reacts with the antigen 
receptor expressed on Jurkat. 
T3-negative Mutants of Jurkat Fail to Express the Idiotypic Determinants Recognized 
by C305. In a previous tudy (16), a T3-negative mutant of Jurkat produced in 
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FIGURE 2. C305 reacts with a heterodimer expressed on the surface ofJurkat cells. Cell 
surface molecules ofJurkat were iodinated, solubilized inNonidet P-40, isolated, and electro- 
phoresed by SDS-PAGE as described in Materials and Methods. Molecules in lanes A-E and 
F-G were isolated and electrophoresed under educing and nonreducing conditions, respec- 
tively. Antibodies u ed for the isolation were as follows: (A) MOPC-195 (IgG), nonreactive 
with Jurkat; (B) anti-Leu-4, reactive with T3; (C) W6132, reactive with HLA; (D and G) 104E 
(IgM), nonreactive with Jurkat; (E andF) C305, reactive with the putative antigen receptor 
expressed on Jurkat. 
this laboratory was described. This mutant, S.5, was produced by mutagenization 
with EMS followed by negative selection with OKT3 and complement and 
subsequent positive selection of cells lacking T3 by flow cytometry. Since the 
expression of T3 has been associated with the antigen receptor on T cell clones, 
it was of interest to examine S.5 for the expression of  the determinants recognized 
by C305. 
Initial studies suggested that, indeed, S.5 failed to express antigenic determi- 
nants recognized by C305. This was more rigorously assessed in quantitative 
absorption studies. Whereas the wild-type, T3-bearingJurkat cells absorbed anti- 
T3 antibody activity in a dose-dependent fashion, neither S.5 nor the B cell line 
were able to absorb the anti-T3 activity (Fig. 3A). From these results it can be 
deduced that S.5 and the B cell line express <%4th the quantity of T3 that is 
expressed on Jurkat. Similarly, although Jurkat cells were readily able to absorb 
C305 activity, both S.5 and the B cell line failed to absorb C305 (Fig. 3B). These 
results suggest hat S.5 not only failed to express detectable T3 determinants 
but also lacked detectable determinants recognized by C305. 
In further studies, depicted in Fig. 4, the specificity of  the lack of expression 
of T3 and determinants recognized by C305 on S.5 was examined by indirect 
immunofluorescence as assessed by flow cytometry. The histograms obtained 
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TABLE I 
C305 Can Activate Jurkat 
1289 
Antibody Specificity Isotype 
IL-2 (U/ml) 
-PMA +PMA 
OKT3 T3 IgG 2 0 109 + 30.0 
C305 Antigen receptor IgM 0 119 + 11.1 
Anti-Leu- 1 T 1 IgG 2 0 0 
Anti-Leu-5 T11 IgG 1 0 0 
C373 T11 IgM 0 0 
W6/32 HLA IgG 2 0 0 
Jurkat cells, 1 X 106/ml, were stimulated with culture supernatants of C305 or 
C373 (1:20 final dilution) or commercial ntibodies (1:100 final dilution) in the 
absence or presence of PMA (50 ng/ml) for 24 h. Resultant IL-2 activity in the 
culture supernatants were assessed as described. Results represent the mean + 
SEM of three experiments and are expressed as units of IL-2 per milliliter. 
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FIGURE 3. T3 antigenic determinants and determinants recognized by C305 are lost concom- 
itantly on mutants of Jurkat as assessed by quantitative absorption. 100 #1 of a 1:800 dilution 
of OKT3 (A) or a 1:1,000 of C305 (B) were absorbed on decreasing numbers of Jurkat (I), 
S.5 (O), J.RT-C305.6 (A), or an EBV-transformed B cell line (A). Residual antibody activity in 
the absorbed supernatants was assessed in an antibody plus complement-mediated assay using 
5tCr-labeled Jurkat cells as described in Materials and Methods. The dashed lines represent 
the cytolytic activities of the unabsorbed antibodies. 
with S.5 cells stained with anti-T3 (Fig. 4F) or C305 (Fig. 4G) monoclonal 
antibodies were not appreciably different han those obtained with the negative 
control antibodies. The fluorescent histograms obtained when S.5 was stained 
with anti-Leu-1 (Fig. 4H, anti-T1), anti-Leu-5 (Fig. 41, anti-T11), and anti-HLA 
(Fig. 4J) demonstrate hat S.5, like the wild-type Jurkat cells, express determi- 
nants detected by these antibodies. The inability to detect T3 determinants on 
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FIGURE 4. Specific loss of T3 antigenic determinants and determinants recognized by C305 
on mutants ofJurkat. Jurkat (A-E), S.5 (F-J), J.RT-T3.1 (K-O), and J.RT-C305.6 (P-T) were 
assessed for their expression ofthe indicated antigenic specificities by indirect immunofluo- 
rescence and flow cytometric analysis (heavy lines). In each case, the histogram obtained with 
a nonreactive control antibody (light line) is shown for comparison. 
S.5 by indirect immunofluorescence was confirmed in previous tudies with two 
additional independently derived anti-T3 antibodies, although the chain(s) with 
which these antibodies react has not been firmly established (16). 
The above results suggested that there might be an obligate requirement for 
the coexpression o fT3  and the antigen receptor. To further examine this notion, 
Jurkat cells were independently mutagenized using either EMS or 7 radiation in 
three separate xperiments. An aliquot of cells was then treated with either anti- 
T3 plus complement or C30fi plus complement. Anti-T3-treated cells were then 
selected for T3 negativity and C305-treated cells for C305 negativity on a 
fluorescence-activated c ll sorter. Sorted cells were then cloned by limiting 
dilution and screened for the absence of determinants recognized by the antibody 
used in the selection procedure. In four independent mutagenizations, regardless 
of the mutagen, or the antibody used in the selection, every negative clone 
analyzed (n = 30) failed to express either T3 or the antigenic determinants 
recognized by C305 (summarized in Table II). For example, J.RT-C305.6, a 
radiation-induced mutant selected for its failure to react with C305, failed to 
express molecules detected by anti-T3 monoclonal antibodies. The failure to 
detect antigenic determinants of T3 or those recognized by C305 on J.RT- 
C305.6 was confirmed by quantitative absorption (Fig. 3), indirect immunoflu- 
orescence (Fig. 4), and antibody plus complement-mediated cytotoxicity (data 
not shown). Similar results were obtained with the other negative clones listed 
in Table II. These results provide further support for the notion that T3 and 
the antigen receptor are associated on the plasma membrane. More importantly, 
they suggest an obligate requirement for the coexpression of T3 and the antigen 
receptor. 
In the course of screening for T3-negative mutants, several clones were 
detected that expressed a markedly diminished but not absent level of T3. One 
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TABLE II 
Mutants of Jurkat Demonstrate an Obligate Requirement for the Coexpression fT3 and the 
Antigen Receptor 
Experi- Cell Mutagen 
ment 
Antibody Relative antigen expression* 
Selection T3 C305 T1 T11 HLA 
1 S.5 EMS OKT3 
J.T30.7 EMS OKT3 
2 J.RT-T3.1 Radiation OKT3 
J.RT-C305.6 Radiation C305 
3 J.EMS-T3.3 EMS OKT3 
J.EMS-C305.1 EMS C305 
4 J.RT3-T3.5 Radiation OKT3 
J.RT3.C305.6 Radiation C305 
_ - -  +++ +++ +++ 
+ + +++ +++ +++ 
B - -  +++ +++ +++ 
- -  +++ +++ +++ 
- -  +++ +++ +++ 
- -  +++ +++ +++ 
- -  +++ +++ +++ 
- -  +++ +++ +++ 
A summary of the phenotype of the indicated mutants of Jurkat as assessed by indirect immunoflu- 
orescence/flow cytometry, quantitative absorption, or antibody and complement-mediated cytolysis 
is presented (results represent at least three separate assays for each cell). Jurkat cells were 
mutagenized with EMS (200 t~g/ml) or gamma radiation and mutants were selected with the 
indicated antibody as described in Materials and Methods. 
* The relative antigen expression of the indicated mutants was compared with the expression of 
these antigens on the wild-type Jurkat cells, and the density of these antigens on the wild type is 
arbitrarily designated (+++). A designation of (+) represents an ~ 10-fold decrease in the level of 
detectable antigen assessed by flow cytometry and quantative absorption; (-) indicates the antigen 
was undetectable in any of the three assays. 
such clone, JT30.7 (Table II), derived by EMS mutagenization a d selection 
with OKT3 plus complement, was studied in detail to examine the relative 
density of T3 and determinants detected by C305. Jurkat, J.T30.7, and J.RT- 
T3.1 (a T3/antigen receptor-negative c ll selected for T3 negativity after 
radiation-induced mutagenesis) were exposed to saturating quantities of OKT3, 
C305, anti-Leu-5, or W6/32, followed by a fluoresceinated anti-mouse Ig, and 
the relative amounts of bound antibody were assessed by flow cytometric analysis 
(Table III). The mean channel fluorescence (MCF) obtained withJ.T30.7 stained 
with OKT3 or C305 (57 and 63, respectively) were greater than the MCF 
obtained with the negative control antibody (48) but substantially less than those 
obtained with the wild-type, Jurkat cells (130 and 107, respectively). In other 
words, a mutant hat expressed an intermediate d nsity of T3 also expressed an 
intermediate density of determinants detected by C305. These differences in 
MCF obtained with J.T30.7 represent nearly a 10-fold decrease in relative 
fluorescence intensity obtained with Jurkat cells stained with OKT3 or C305. 
The MCF of the T3/receptor-negative mutant (J.RT-T3.1) stained with OKT3 
or C305 did not differ from that obtained with MOPC-195, the negative control 
antibody (Table IV). The specificity of the changes in T3 and antigen receptor 
expression oted is demonstrated by the relatively equivalent amounts of T11 
and HLA antigens on all three cells (Table III). These results lend further 
support o the notion that there is a structural requirement for the coexpression 
of both T3 and antigen receptor molecules and suggest hat they may be 
stoichiometrically related on the cell surface. 
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TABLE II I  
Comparable Decrease in the Density of T3 and Determinants Detected 
by C305 on Mutants of Jurkat 
Antibody 
Mean channel fluorescence* 
Jurkat J.T30.7 J.RT-T3.1 
MOPC-195 48 48 47 
OKT3 130 57 46 
C305 107 63 46 
Anti-Leu-5 138 129 128 
W6/32 156 167 162 
The indicated cells were stained with saturating amounts of the indicated 
monoclonal ntibodies followed by a saturating quantity of fluorescein- 
ated anti-mouse Ig. The relative fluorescence of the stained cells was 
determined on a FACS IV flow cytometer. 
* The MCF was determined from the fluorescence histograms obtained 
with the indicated cells prepared with the indicated monoclonal ntibod- 
ies. Unimodal distributions were obtained with each cell preparation. A 
10-fold change in relative mean fluorescence intensity would be equiv- 
alent o a change of 57 channels in MCF. 
TABLE IV 
Ability of Various Stimuli to Activate T3/Antigen Receptor-negative 
Mutants of Jurkat 
IL-2 activity (U/ml) 
Stimulus Responding cell 
Jurkat S.5 J.RT-T3.1 J.RT-C305.6 
0 0 0 0 0 
PHA 24.1 0 0 0 
PMA 0 0 0 0 
PHA + PMA 172 5.1 0 0 
OKT3 + PMA 79.1 0 0 0 
C305 + PMA 108 0 0 0 
A23187 + PMA 216 98 164 150 
Jurkat or the indicated mutant cells, at 1 x 10S/ml, were cultured in the presence 
of the indicated stimulus for 24 h and the IL-2 activity in the resultant culture 
supernatants were assessed as described in Materials and Methods. Results are 
representative of three separate experiments. 
Failure to Detect Determinants Recognized by C305 on the Antigen Receptor Is Not 
Due to an Altered Epitope. One a l ternat ive  xp lanat ion  for the lack o f  react iv i ty 
o fC305 with such mutants  is that  the C305 ant ibody  recognizes a conformat iona l  
determinant  o f  the ant igen receptor  that  requ i res  the express ion o f  T3 .  As such, 
these determinants  might  not  be expressed on the mutants  because the ant igen 
receptor  might  be present  on the cell membrane in an a l te red  conformat iona l  
state. To  assess this, whole cell lysates o f  iod inated  cell surface prote ins  o f  Ju rkat  
and  such mutants  were ana lyzed by d iagona l  gel e lectrophores is .  Th is  approach,  
used by others,  has demonst ra ted  that  the T cell ant igen receptor  is one o f  only 
a few T cell sur face prote ins  with in tercha in  disul f ide l inkages and,  thus, falls 
be low the d iagonal  (1). Note,  whereas  the ind iv idual  chains o f  the ant igen 
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FIGURE 5. Antigen receptor molecules are undetectable among the iodinated cell surface 
molecules of T3/antigen receptor-negative mutants ofJurkat, l~-I-labeled Jurkat cell surface 
molecules isolated with C305 (A) is compared with the iodinated cell surface proteins repre- 
sented in whole cellular lysates of Jurkat (B), S.5 (C), and J.RT-C305.6 (D). SDS-PAGE was 
performed of samples under nonreducing conditions in the first dimension (from left to right) 
followed by reduction and electrophoresis in thesecond dimension (from t p to bottom). 
receptor molecule on Jurkat is demonstrated below the diagonal using the Jurkat 
whole cell lysate (Fig. 5B) in a position identical to the immunoprecipitate 
prepared with C305 and Jurkat cells (Fig. 5A), no such proteins were detectable 
in either S.5 (Fig. 5 C) or J .RT-C305.6  (Fig. 5D). These results demonstrate that 
the failure to detect determinants recognized by C305 on these mutants is due 
to the absence of  the antigen receptor on the surface of  these cells and not due 
to an altered conformation of  the antigen receptor. 
Ability of T3 and Antigen Receptor-Negative Mutants To Be Activated by a Variety 
of Stimuli. Functional studies were performed to assess both the absence of T3  
and the antigen receptor on these mutants of  Jurkat as well as the requirement 
for the participation of  these molecules in PHA-induced activation of  Jurkat. 
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Representative r sults obtained with three of these mutants are compared with 
those obtained with the wild-type Jurkat cells in Table IV. All three mutants 
failed to produce detectable IL-2 in response to either anti-T3 plus PMA or 
C305 plus PMA. This is in marked contrast o the response of Jurkat to these 
stimuli (79.1 and 172 U/ml, respectively). Moreover, these mutants exhibited 
either undetectable or markedly diminished responses to either PHA alone or 
PHA plus PMA compared with the responses obtained with Jurkat cells (Table 
IV). The low level of IL-2 production by S.5 in response to PHA and PMA has 
been discussed in a previous report (16). The failure of these negative mutants 
to respond to these stimuli could not be attributed to their inability to make IL- 
2. In previous studies, Jurkat and S.5 cells could be activated by the calcium 
ionophore A23187 if PMA was also added (16). Responses nearly equivalent to 
those obtained with the wild-type Jurkat cells were observed when any of the 
mutants were stimulated with A23187 plus PMA (Table IV). These results 
strongly suggest hat the expression of T3 and/or the antigen receptor are 
required for the activation of Jurkat by the lectin PHA. Moreover, the require- 
ment for T3 and/or the antigen receptor expression can be bypassed by a calcium 
ionophore. 
Discussion 
These studies examined the association between T3, a set of three distinct 
polypeptides, and the putative T cell antigen receptor, an 80-90 kD heterodimer, 
expressed on a human T cell line Jurkat. Anti-T3 and a monoclonal antibody 
reactive with idiotypic-like determinants expressed on this putative antigen 
receptor were used to select mutants of Jurkat that failed to express either T3 
or the antigen receptor. Regardless of the mutagen used, or the antibody used 
in the selection, all negative mutants failed to express both T3 and such putative 
antigen receptor molecules. Since four separate mutagenizations were per- 
formed, a minimum of four independently derived mutants were studied. In an 
additional mutant, which expressed a diminished but not absent quantity of T3 
determinants, the density of antigen receptor determinants was also comparably 
diminished, suggesting a stoichiometric relation between T3 and the antigen 
receptor. These results extend those of others which suggest an association 
between T3 and the antigen receptor (2, 9-12). They further indicate that there 
is an obligate requirement for the coexpression of T3 and such antigen receptor 
molecules on the surface of T cells. 
The failure of all of the negative mutants described in this report to express 
both T3 and the antigen receptor suggests an intimate structural relationship 
between these molecules. The most direct demonstration of a close spatial 
association between T3 and the antigen receptor is provided by the studies of 
Allison and Lanier (22). In these studies, a cross-linking reagent with a 12 /k 
span was able to specifically cross-link T3 and the heterodimer expressed on a 
human T cell tumor as well as similar peptides on a murine T cell tumor. 
The nature of the mutation in any of the mutants tudied in this report is not 
clear. However, it is clear that in each mutant here is a resultant loss of expression 
or comparable decrease in the level of expression of both the antigen receptor 
and T3 antigenic determinants. Several models could account for the associated 
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loss of expression of both T3 and the antigen receptor: (a) Interaction between 
T3 and the antigen receptor might be required for these molecules to assume 
and maintain a stable conformation i  the plasma membrane. This situation 
might be analogous to similar associations observed with other cell surface 
molecules. For example, class I major histocompatibility complex (MHC) mole- 
cules are not expressed unless/3~-microglobulin is synthesized (23); immunoglob- 
ulin heavy chains are not expressed on the cell membrane during B cell ontogeny 
until light chain synthesis occurs (24); and class II MHC antigen expression 
requires the expression of both a and fl chains (25). (b) A common regulatory or 
transport mechanism and/or some posttranslational modification may be re- 
quired for the coexpression of T3 and the antigen receptor. Such a defect could 
account for the observed failure of expression, but it would seem unlikely that 
in several independently derived mutants this transport system would always be 
the target of the mutation. (c) A common precursor might be involved in the 
synthesis of both T3 and the antigen receptor. Since five polypeptide chains are 
involved, this model seems highly unlikely. (d) The genes encoding both T3 and 
the antigen receptor could be closely linked and, thus, deletion of a large section 
of the genetic material coding for these proteins could result in their concomitant 
loss. Although there are examples of this in the MHC system involving radiation- 
induced mutants, it seems unlikely that independently derived mutants using 
EMS should also result in such extensive loss of expression (26). Given the 
physical association that has been demonstrated between T3 and the antigen 
receptor in previous tudies, it would seem that the first alternative of a structural 
requirement for insertion and stable conformation of these molecules in the 
plasma membrane is the most likely alternative. However, further studies using 
biosynthetic labeling to attempt o isolate any of these proteins that might be 
present in the cytoplasm of these mutants, use of the recently described cDNA 
probes of these genes to examine these mutants for the presence of appropriate 
transcripts, and fusion of mutant cells in complementation studies are required 
to further characterize the nature of the induced mutations. Such studies may 
help define the functional requirement for association between T3 and the T 
cell antigen receptor. 
The requirement for coexpression of T3 and the antigen receptor on the 
plasma membrane of Jurkat may also be important in the expression of these 
molecules during thymocyte ontogeny. Although transcripts or even protein of 
the antigen receptor may be synthesized in many thymocytes, cell surface 
expression of such heterodimers appears to be limited to a minority of thymo- 
cytes, the more functionally mature population that expresses T3 (12, 27, 28). 
In keeping with these observations and the studies reported here, the expression 
of the T cell antigen receptor may mimic the pattern of differentiation seen in 
B cells; i.e., expression of membrane receptor immunoglobulin does not occur 
until light chain synthesis occurs (24). Thus, although the T cell antigen receptor 
may be synthesized, cell surface expression is delayed until the synthesis of T3 
occurs. 
PHA and other lectins have been used to activate T cells. In general, only 
immunologically competent T cells respond to such mitogens. PHA and other 
lectins bind to a large number of different glycosylated cell surface proteins. 
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However, the specific molecules involved in the activation of T cells by lectins 
have not been defined. The present studies demonstrate hat activation of Jurkat 
by the lectin PHA requires the expression of T3 and/or the antigen receptor, 
suggesting that PHA activates Jurkat, at least in part, by binding to T3 and/or 
the antigen receptor. Previous studies from this laboratory (16) demonstrated 
that PHA induces an increase in cytoplasmic free calcium in Jurkat but fails to 
induce this change in the T3-negative mutant S.5. These results together with 
the studies reported here suggest hat PHA activates Jurkat by binding to T3 
and/or the antigen receptor. 
Recent studies by Moretta et al. (29) have suggested that the antigen recogni- 
tion capacity of T cell clones could be dissociated from T3 expression. These 
authors demonstrated that if T3 antigen expression was modulated off of 
ailoreactive cytolytic T cell clones, some clones were still able to recognize 
alloantigens on target cells. However, from the flow cytometer profiles presented 
by these authors, it is clear that responsive, modulated clones have a markedly 
reduced ensity of T3 but are not truly T3 negative. In this regard, the data 
obtained with J.T30.7, a clone that expressed ~l/,0th the density of T3/antigen 
receptor determinants that the wild-type Jurkat expressed, is of relevance. 
Despite the diminished ensity of T3/antigen receptor determinants onJ.T30.7, 
this cell was able to be activated by anti-T3, C305, or PHA plus PMA to 
magnitudes comparable to those observed with Jurkat cells (data not presented). 
This was in marked contrast o the absent responses observed with T3/antigen 
receptor-negative mutants. Thus, it would appear that a diminished ensity of 
T3/antigen receptor expression may be sufficient for full cell activation and may 
help explain the apparent discrepancy between the observations of Moretta et 
al. (29) and those obtained in this report. Furthermore, studies using cells such 
asJ.T30.7 and other mutants with even less T3/antigen receptor expression may 
provide a useful model for examining the minimal number of receptors required 
for cell activation. 
It is clear that T3 and the antigen receptor are associated on the cell surface. 
The functional activity of this complex includes an antigen-binding capacity and 
transmission of one of the transmembrane signals required for T cell activation. 
This transmembrane signal appears to involve events associated with an increase 
in cytoplasmic free calcium ([Ca++]i) (16). The relative role of T3 or the antigen 
receptor in mediating the effector function involved in generating this transmem- 
brane signal is not clear. Thus, it is not clear whether the antigen receptor alone, 
after interaction with antigen, can induce a rise in [Ca++]i or whether an 
interaction with T3 is required for the signal transduction to occur. Further 
studies characterizing the relationship of T3 and the antigen receptor through 
the use of mutants, such as those described in this report, may help define the 
relative functions of these molecules in mediating such a transmembrane activa- 
tion signal as well as defining their structural roles required for plasma membrane 
coexpression. 
Summary 
The association between T3 and the T cell antigen receptor was examined 
using the T3 bearing T cell leukemic line Jurkat. A monoclonal antibody, C305, 
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was produced, which reacted with idiotypic-like determinants expressed on 
Jurkat. The molecule with which this antibody reacted was a disulfide-linked 
heterodimer of 90 kD, composed of polypeptides of 42 and 54 kD. Thus, C305 
reacted with a molecule with characteristics of the putative T cell antigen receptor 
described by others. A series of mutants of Jurkat, induced with ethyl methane 
sulfonate or radiation, was selected for T3 or antigen receptor negativity. In 
every instance, there was a concomitant loss of both T3 and the antigen receptor 
as assessed by quantitative absorption, indirect immunofluorescence, and anti- 
body plus complement-mediated cytotoxicity. The absence of antigen receptor 
molecules was confirmed on diagonal gels, excluding the possibility that confor- 
mational changes of the antigen receptor on such T3-negative mutants were 
responsible for the failure of such mutants to react with C305. Moreover, in a 
mutant hat expressed a marked decrease in the level of T3 expression, there 
was a comparable decrease in the expression of antigen receptor determinants. 
These results uggest that there is an obligate requirement for the coexpression 
of T3 and the T cell antigen receptor. Furthermore, attempts to activate such 
mutants with the lectin phytohemagglutinin suggested that the expression of T3 
and/or the antigen receptor was required for activation of these cells. 
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